Angeles Baquerizo
Transplant Surgery · la Jolla, CANPI 1053425330
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $24,000 of the $28,019 with a category attached, or 85.7%. Organox Ltd accounts for 91.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $24,848 and has fallen 98.0% since, to $508 in 2025. Among transplant surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $571.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organox Ltd$26K
- Gilead$969
- AbbVie$272
- Eisai Inc.$200
- Takeda Pharmaceuticals U.S.A., Inc.$190
- Xvivo Perfusion Inc.$185
- plus $473 from 9 others
Across 2 payments — averaging $522.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$1K
What the payments were for
- Consulting fees$24,00086%
- Travel & lodging$1,4585%
- Food & beverage$2,5409%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organox Ltd | 5 | $25,729 |
| Gilead | 14 | $969 |
| AbbVie | 3 | $272 |
| Eisai Inc. | 7 | $200 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $190 |
| Xvivo Perfusion Inc. | 1 | $185 |
| Biocompatibles, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 3 | $111 |
| Merck | 6 | $104 |
| Novo Nordisk | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Orphalan Inc | 1 | $21 |
| Bayer | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- METRA$1,624
- Harvoni$375
- Mavyret$250
- XVIVO Perfusion System (XPS)$185
- THERASPHERE-BIO$124
- LIVTENCITY$119
- LENVIMA$111
How this compares
$28,019 in reported general payments places this provider in the 90th percentile of 56 transplant surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in la Jolla
- Jenny Lamla Jolla$5K
- Jonathan Fisherla Jolla$3K
- Christopher Marshla Jolla$2K
- Dylan Adamsonla Jolla$2K
- Elizabeth SquiersHalf Moon Bay$1.3M
- Myron TongPasadena$99K
- Robert RedfieldOrange$65K
- Yuri GenykLos Angeles$35K
- Navpreet KaurLos Angeles$19K
- Gerald LipshutzLos Angeles$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.